Login / Signup
Making Sense of Phase II Trials for Investigational Agents in COVID-19: The Case of Ilomedin in Mechanically Ventilated Patients.
Fernando Godinho Zampieri
Adit Ginde
Published in:
American journal of respiratory and critical care medicine (2022)
Keyphrases
</>
phase ii
clinical trial
end stage renal disease
open label
coronavirus disease
sars cov
newly diagnosed
ejection fraction
chronic kidney disease
intensive care unit
prognostic factors
acute respiratory distress syndrome